Alvarez-Rodríguez L, Lopez-Hoyos M, Mata C, Marin MJ, Calvo-Alen J, Blanco R, et al. Circulating cytokines in active polymyalgia rheumatica. Ann Rheum Dis. 2010;69(1):263–9.
PubMed
CrossRef
CAS
Google Scholar
Barber HS. Myalgic syndrome with constitutional effects; polymyalgia rheumatica. Ann Rheum Dis. 1957;16(2):230–7.
CAS
PubMed
PubMed Central
CrossRef
Google Scholar
Brassell MP. Teaching patients to cope with polymyalgia rheumatica. Nursing. 1978;8(5):22–4.
CAS
PubMed
CrossRef
Google Scholar
Brown S, Bond D, Waldron N. Less common rheumatological diseases: an introduction. Pract Nurse. 2014;44(9):40–6.
Google Scholar
Bruce W. Senile rheumatic gout. Br Med J. 1888;2(1450):811–3.
CAS
PubMed
PubMed Central
CrossRef
Google Scholar
Crowson CS, Matteson EL. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015. Semin Arthritis Rheum. 2017;47:253–6.
PubMed
PubMed Central
CrossRef
Google Scholar
Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63(3):633–9.
PubMed
PubMed Central
CrossRef
Google Scholar
Dasgupta B. Polymyalgia rheumatica. In: Watts RA, Conaghan PG, Denton C, Foster H, Isaacs J, Muller-Ladner U, editors. Oxford textbook of rheumatology. 4th ed. Oxford, UK: Oxford University Press; 2013. p. 1125–31.
Google Scholar
Dasgupta B, Borg FA, Hassan N, Barraclough K, Bourke B, Fulcher J, et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology. 2010;49(1):186–90, 5p.
PubMed
CrossRef
Google Scholar
Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, et al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012a;71(4):484–92.
PubMed
CrossRef
Google Scholar
Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, et al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012b;64(4):943–54.
PubMed
CrossRef
Google Scholar
De Bandt M. Current diagnosis and treatment of polymyalgia rheumatica. Joint Bone Spine. 2014;81(3):203–8, 6p.
PubMed
CrossRef
Google Scholar
Dejaco C, Duftner C, Cimmino MA, Dasgupta B, Salvarani C, Crowson CS, et al. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis. 2011;70(3):447–53.
PubMed
CrossRef
Google Scholar
Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74(10):1799–807.
CAS
PubMed
CrossRef
Google Scholar
Dixon WG, Bansback N. Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know. Ann Rheum Dis. 2012;71(11):1761–4.
CAS
PubMed
CrossRef
Google Scholar
Duarte C, Ferreira RJO, Mackie SL, Kirwan JR, Pereira dS. Outcome measures in polymyalgia rheumatica. A systematic review. J Rheumatol. 2015;42(12):2503–11.
CAS
PubMed
CrossRef
Google Scholar
Falsetti P, Acciai C, Volpe A, Lenzi L. Ultrasonography in early assessment of elderly patients with polymyalgic symptoms: a role in predicting diagnostic outcome? Scand J Rheumatol. 2011;40(1):57–63.
CAS
PubMed
CrossRef
Google Scholar
Fardet L. Glucocorticoid-induced adverse events in patients with giant cell arteritis or polymyalgia rheumatica. Rev Med Interne. 2013;34(7):438–43.
CAS
PubMed
CrossRef
Google Scholar
Fardet L, Fève B. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. Drugs. 2014;74(15):1731–45, 15p.
CAS
PubMed
CrossRef
Google Scholar
Frediani B, Falsetti P, Storri L, Bisogno S, Baldi F, Campanella V, et al. Evidence for synovitis in active polymyalgia rheumatica: sonographic study in a large series of patients. J Rheumatol. 2002;29(1):123–30.
PubMed
Google Scholar
Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137–45.
CAS
PubMed
CrossRef
Google Scholar
Gonzalez-Gay M, Vazquez-Rodriguez T, Lopez-Diaz M, Miranda-Filloy J, Gonzalez-Juanatey C, Martin J, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61(10):1454–61.
PubMed
CrossRef
Google Scholar
Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987–94. J Rheumatol. 1997;24(9):1739–43.
CAS
PubMed
Google Scholar
Green DJ, Muller S, Mallen CD, Hider SL. Fatigue as a precursor to polymyalgia rheumatica: an explorative retrospective cohort study. Scand J Rheumatol. 2015;44(3):219–23, 5p.
CAS
PubMed
CrossRef
Google Scholar
Hayward RA, Rathod T, Muller S, Hider SL, Roddy E, Mallen CD. Association of polymyalgia rheumatica with socioeconomic status in primary care: a cross-sectional observational study. Arthritis Care Res (Hoboken). 2014;66(6):956–60.
CrossRef
Google Scholar
Helliwell T, Hider SL, Mallen CD. Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice. Br J Gen Pract. 2013;63(610):e361–6.
PubMed
PubMed Central
CrossRef
Google Scholar
Helliwell T, Brouwer E, Pease CT, Hughes R, Hill CL, Neill LM, et al. Development of a provisional core domain set for polymyalgia rheumatica: report from the OMERACT 12 Polymyalgia Rheumatica Working Group. J Rheumatol. 2016;43(1):182–6.
PubMed
CrossRef
Google Scholar
Hennell SL. Nurse prescribing in rheumatology: a case study. Musculoskeletal Care. 2004;2(1):65–71.
PubMed
CrossRef
Google Scholar
Hennell S, Busteed S, George E. Evidence-based management for polymyalgia rheumatica for rheumatology practitioners, nurses and physiotherapists. Musculoskeletal Care. 2007;5(2):65–71.
PubMed
CrossRef
Google Scholar
Kennedy-Malone L, Enevold GL. Assessment and management of polymyalgia rheumatica in older adults. Geriatr Nurs. 2001;22(3):152–5.
CAS
PubMed
CrossRef
Google Scholar
Kermani TA, Warrington KJ. Polymyalgia rheumatica. Lancet. 2013;381(9860):63–72. North American Edition, 10p.
PubMed
CrossRef
Google Scholar
Kreiner F, Langberg H, Galbo H. Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. Arthritis Rheum. 2010;62(12):3768–75.
PubMed
CrossRef
Google Scholar
Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE. Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol. 2005a;32(1):65–73.
PubMed
Google Scholar
Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE. Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. Arthritis Rheum. 2005b;53(3):395–403.
PubMed
CrossRef
Google Scholar
Leslie M, Fitzgerald DC, Mikanowicz C. Musculoskeletal aching in the older adult: polymyalgia rheumatica and giant cell arteritis. Top Adv Pract Nurs. 2003;3(1):5p.
Google Scholar
Macchioni P, Boiardi L, Catanoso M, Pazzola G, Salvarani C. Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis. 2014;73(6):1190–3.
PubMed
CrossRef
Google Scholar
Mackie SL, Mallen CD. Polymyalgia rheumatica. BMJ. 2013;347:f6937.
PubMed
CrossRef
Google Scholar
Mackie SL, Pease CT. Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips. Postgrad Med J. 2013;89(1051):284–92.
PubMed
CrossRef
Google Scholar
Mackie SL, Arat S, da Silva J, Duarte C, Halliday S, Hughes R, et al. Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR. J Rheumatol. 2014;41(4):819–23.
PubMed
CrossRef
Google Scholar
Muller S, Hider SL, Belcher J, Helliwell T, Mallen CD. Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Ann Rheum Dis. 2014;73(10):1769–73.
PubMed
CrossRef
Google Scholar
Muller S, Hider SL, Helliwell T, Lawton S, Barraclough K, Dasgupta B, et al. Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study. Arthritis Res Ther. 2016;18:200.
PubMed
PubMed Central
CrossRef
CAS
Google Scholar
Muller S, O’Brien A, Helliwell T, Hay CA, Gilbert K, Mallen CD, et al. Support available for and perceived priorities of people with polymyalgia rheumatica and giant cell arteritis: results of the PMRGCAuk members’ survey 2017. Clin Rheumatol. 2018;37(12):3411–8.
PubMed
CrossRef
Google Scholar
Owen CE, Buchanan RRC, Hoi A. Recent advances in polymyalgia rheumatica. Intern Med J. 2015;45(11):1102–8.
CAS
PubMed
CrossRef
Google Scholar
Partington R, Helliwell T, Muller S, Abdul Sultan A, Mallen C. Comorbidities in polymyalgia rheumatica: a systematic review. Arthritis Res Ther. 2018a;20(1):258.
PubMed
PubMed Central
CrossRef
Google Scholar
Partington RJ, Muller S, Helliwell T, Mallen CD, Sultan AA, Abdul Sultan A. Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study. Ann Rheum Dis. 2018b;77(12):1750–6.
PubMed
CrossRef
Google Scholar
Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T, et al. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med. 2018;16(1):4.
PubMed
PubMed Central
CrossRef
CAS
Google Scholar
Petri H, Nevitt A, Sarsour K, Napalkov P, Collinson N. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities. Arthritis Care Res (Hoboken). 2015;67(3):390–5.
CAS
CrossRef
Google Scholar
Raheel S, Shbeeb I, Crowson CS, Matteson EL. Epidemiology of polymyalgia rheumatica 2000–2014 and examination of incidence and survival trends over 45 years: a population-based study. Arthritis Care Res (Hoboken). 2017;69(8):1282–5.
CrossRef
Google Scholar
Ruta S, Rosa J, Navarta DA, Saucedo C, Catoggio LJ, Monaco RG, et al. Ultrasound assessment of new onset bilateral painful shoulder in patients with polymyalgia rheumatica and rheumatoid arthritis. Clin Rheumatol. 2012;31(9):1383–7.
PubMed
CrossRef
Google Scholar
Sakellariou G, Iagnocco A, Riente L, Ceccarelli F, Carli L, Di Geso L, et al. Ultrasound imaging for the rheumatologist XLIII. Ultrasonographic evaluation of shoulders and hips in patients with polymyalgia rheumatica: a systematic literature review. Clin Exp Rheumatol. 2013;31(1):1–7.
PubMed
Google Scholar
Salvarani C, Macchioni PL, Tartoni PL, Rossi F, Baricchi R, Castri C, et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol. 1987;5(3):205–15.
CAS
PubMed
Google Scholar
Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970–1991. Arthritis Rheum. 1995;38(3):369–73.
CAS
PubMed
CrossRef
Google Scholar
Salvarani C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, et al. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective follow up study. Arthritis Rheum. 2005;53(1):33–8.
PubMed
CrossRef
Google Scholar
Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372(9634):234–45.
PubMed
CrossRef
Google Scholar
Salvarani C, Barozzi L, Boiardi L, Pipitone N, Bajocchi GL, Macchioni PL, et al. Lumbar interspinous bursitis in active polymyalgia rheumatica. Clin Exp Rheumatol. 2013;31(4):526–31.
PubMed
Google Scholar
Seitz M. Polymyalgia rheumatica: what is the current status? Z Rheumatol. 2015;74(6):507–10.
CAS
PubMed
CrossRef
Google Scholar
Shbeeb I, Challah D, Raheel S, Crowson CS, Matteson EL. Comparable rates of glucocorticoid associated adverse events in patients with polymyalgia rheumatica and comorbidities in the general population. Arthritis Care Res (Hoboken). 2018;70(4):643–7.
CAS
CrossRef
Google Scholar
Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis. 2006;65(8):1093–8.
CAS
PubMed
PubMed Central
CrossRef
Google Scholar
Straub RH, Cutolo M. Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica. J Rheumatol. 2006;33(7):1219–23.
PubMed
Google Scholar
Twohig H, Mitchell C, Mallen C, Adebajo A, Mathers N. ‘I suddenly felt I’d aged’: a qualitative study of patient experiences of polymyalgia rheumatica (PMR). Patient Educ Couns. 2015;98(5):645–50.
PubMed
CrossRef
Google Scholar
Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003;48(11):3224–9.
PubMed
CrossRef
CAS
Google Scholar
Vivekanantham A, Blagojevic-Bucknall M, Clarkson K, Belcher J, Mallen CD, Hider SL. How common is depression in patients with polymyalgia rheumatica? Clin Rheumatol. 2018;37(6):1633–8.
PubMed
CrossRef
Google Scholar
Whitlock M, Hollywood J. Treatment guidelines for polymyalgia rheumatica: the nursing perspective. Rheumatology. 2014;53:i10.
CrossRef
Google Scholar
Yates M, Graham K, Watts RA, MacGregor AJ. The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population. BMC Musculoskelet Disord. 2016;17:285.
PubMed
PubMed Central
CrossRef
Google Scholar